These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24603516)

  • 1. The local lymph node assay in 2014.
    Basketter DA; Gerberick GF; Kimber I
    Dermatitis; 2014; 25(2):49-50. PubMed ID: 24603516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contact allergenic potency: correlation of human and local lymph node assay data.
    Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
    Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative relationship between the local lymph node assay and human skin sensitization assays.
    Schneider K; Akkan Z
    Regul Toxicol Pharmacol; 2004 Jun; 39(3):245-55. PubMed ID: 15135206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative responses in the local lymph node assay associated with concomitant exposure to 1,4-phenylenediamine and methyldibromo glutaronitrile: evidence for synergy?
    Jowsey IR; Basketter DA; Irwin A
    Contact Dermatitis; 2008 Aug; 59(2):90-5. PubMed ID: 18759875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative approach to assess the potency of skin sensitizers in the elicitation phase.
    Ezendam J; Vermeulen JP; de Klerk A; de Jong WH; van Loveren H
    Toxicology; 2012 Sep; 299(1):20-4. PubMed ID: 22564262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Categorization of chemicals according to their relative human skin sensitizing potency.
    Basketter DA; Alépée N; Ashikaga T; Barroso J; Gilmour N; Goebel C; Hibatallah J; Hoffmann S; Kern P; Martinozzi-Teissier S; Maxwell G; Reisinger K; Sakaguchi H; Schepky A; Tailhardat M; Templier M
    Dermatitis; 2014; 25(1):11-21. PubMed ID: 24407057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay.
    Jowsey IR; Clapp CJ; Safford B; Gibbons BT; Basketter DA
    Cutan Ocul Toxicol; 2008; 27(2):67-75. PubMed ID: 18568891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The local lymph node assay and skin sensitization testing.
    Kimber I; Dearman RJ
    Methods Mol Biol; 2010; 598():221-31. PubMed ID: 19967517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of relative skin sensitizing potency using the local lymph node assay: a comparison of formaldehyde with glutaraldehyde.
    Hilton J; Dearman RJ; Harvey P; Evans P; Basketter DA; Kimber I
    Am J Contact Dermat; 1998 Mar; 9(1):29-33. PubMed ID: 9471984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contact and respiratory sensitizers can be identified by cytokine profiles following inhalation exposure.
    De Jong WH; Arts JH; De Klerk A; Schijf MA; Ezendam J; Kuper CF; Van Loveren H
    Toxicology; 2009 Jul; 261(3):103-11. PubMed ID: 19422874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.
    Betts CJ; Dearman RJ; Heylings JR; Kimber I; Basketter DA
    Contact Dermatitis; 2006 Sep; 55(3):140-7. PubMed ID: 16918612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
    J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updating the skin sensitization in vitro data assessment paradigm in 2009--a chemistry and QSAR perspective.
    Roberts DW; Patlewicz GY
    J Appl Toxicol; 2010 Apr; 30(3):286-8; discussion 289. PubMed ID: 20131408
    [No Abstract]   [Full Text] [Related]  

  • 14. Development and utilization of an ex vivo bromodeoxyuridine local lymph node assay protocol for assessing potential chemical sensitizers.
    Williams WC; Copeland C; Boykin E; Quell SJ; Lehmann DM
    J Appl Toxicol; 2015 Jan; 35(1):29-40. PubMed ID: 24532485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of ethanol:diethylphthalate as a vehicle for the local lymph node assay.
    Betts CJ; Beresford L; Dearman RJ; Lalko J; Api AP; Kimber I
    Contact Dermatitis; 2007 Feb; 56(2):70-5. PubMed ID: 17244073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the skin sensitising potency of the lower alkyl methacrylate esters.
    Kimber I; Pemberton MA
    Regul Toxicol Pharmacol; 2014 Oct; 70(1):24-36. PubMed ID: 24956587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin irritation and sensitization: mechanisms and new approaches for risk assessment.
    Basketter D; Darlenski R; Fluhr JW
    Skin Pharmacol Physiol; 2008; 21(4):191-202. PubMed ID: 18509253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nothing is perfect, not even the local lymph node assay: a commentary and the implications for REACH.
    Basketter DA; McFadden JF; Gerberick F; Cockshott A; Kimber I
    Contact Dermatitis; 2009 Feb; 60(2):65-9. PubMed ID: 19207375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin sensitization: strategies for the assessment and management of risk.
    Basketter DA
    Br J Dermatol; 2008 Aug; 159(2):267-73. PubMed ID: 18503602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reduced local lymph node assay: the impact of group size.
    Ryan CA; Chaney JG; Kern PS; Patlewicz GY; Basketter DA; Betts CJ; Dearman RJ; Kimber I; Gerberick GF
    J Appl Toxicol; 2008 May; 28(4):518-23. PubMed ID: 17879259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.